Literature DB >> 8379690

Ki-67 antigen expression and growth pattern of basal cell carcinomas.

H P Baum1, I Meurer, G Unteregger.   

Abstract

The expression and location of the Ki-67 antigen was investigated in 62 basal cell carcinomas (BCC) using immunostaining techniques (PAP and APAAP) on cryostat sections. The tumor samples were classified into three groups according to microarchitecture (nodular, superficial or fibrosing). The Ki-67 growth fraction displayed great variation between tumors belonging to the same group (nodular type, 7-67%; superficial type, 18-49%; fibrosing type 4-33%). In nodular and superficial BCC formations Ki-67 reactivity was confined either to the nuclei of three to five rows of peripheral cells, or Ki-67-positive nuclei were scattered in the central as well as in the peripheral parts of the tumor strands. The staining patterns varied in an individual tumor. Areas with a high Ki-67 labelling index often occurred adjacent to rather quiescent strands, suggesting that an individual tumor is not in a uniform state of proliferation. So far there are no experimental findings on the regulation of proliferative activity in BCCs. In view of the fact that BCCs are rather slow-growing tumors, the large Ki-67 growth fractions indicate a prolonged duration of the cell cycle or a considerable continuous loss of cells. As the microarchitecture of BCCs is much more complex than would be expected from the location of their Ki-67-positive cells, the growth pattern is probably determined to a high degree by the adjacent connective connective tissue (physical properties and texture of collagen and elastic fibres, enzyme activity of fibroblasts).

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8379690     DOI: 10.1007/bf00371599

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  26 in total

1.  Immunoelectron-microscopic localization of a proliferation-associated antigen Ki-67 in MCF-7 cells.

Authors:  J Isola; H Helin; O P Kallioniemi
Journal:  Histochem J       Date:  1990-09

2.  Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67.

Authors:  J Gerdes; L Li; C Schlueter; M Duchrow; C Wohlenberg; C Gerlach; I Stahmer; S Kloth; E Brandt; H D Flad
Journal:  Am J Pathol       Date:  1991-04       Impact factor: 4.307

3.  Cell proliferation kinetics of cultured human keratinocytes and fibroblasts measured using a monoclonal antibody.

Authors:  T Oku; M Takigawa; M Yamada
Journal:  Br J Dermatol       Date:  1987-05       Impact factor: 9.302

4.  Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation.

Authors:  J Gerdes; U Schwab; H Lemke; H Stein
Journal:  Int J Cancer       Date:  1983-01-15       Impact factor: 7.396

5.  Monoclonal antibody Ki-67 defined growth fraction in benign prostatic hyperplasia and prostatic cancer.

Authors:  M P Gallee; E Visser-de Jong; F J ten Kate; F H Schroeder; T H Van der Kwast
Journal:  J Urol       Date:  1989-11       Impact factor: 7.450

6.  Proliferation antigens in cutaneous melanocytic tumors--an immunohistochemical study comparing the transferrin receptor and the Ki 67 antigen.

Authors:  H P Soyer; J Smolle; F M Smolle-Juettner; H Kerl
Journal:  Dermatologica       Date:  1989

7.  Transplantation of human basal cell carcinomas to athymic mice.

Authors:  R E Grimwood; C A Johnson; C F Ferris; D B Mercill; J R Mellette; J C Huff
Journal:  Cancer       Date:  1985-08-01       Impact factor: 6.860

8.  Immunohistochemical assessment of growth fractions in colorectal adenocarcinomas with monoclonal antibody Ki-67. Relation to clinical and pathological variables.

Authors:  G Lanza; L Cavazzini; L Borghi; S Ferretti; F Buccoliero; M Rubbini
Journal:  Pathol Res Pract       Date:  1990-10       Impact factor: 3.250

9.  A new concept of basal cell epitheliomas based on the three-dimensional growth pattern of the superficial multicentric type.

Authors:  S Imayama; Y Yashima; R Higuchi; H Urabe
Journal:  Am J Pathol       Date:  1987-09       Impact factor: 4.307

10.  Carcinoma of the cervix uteri: an assessment of tumour proliferation using the monoclonal antibody Ki67.

Authors:  D C Brown; D Cole; K C Gatter; D Y Mason
Journal:  Br J Cancer       Date:  1988-02       Impact factor: 7.640

View more
  3 in total

1.  Analysis of 1,25-dihydroxyvitamin D(3) receptors (VDR) in basal cell carcinomas.

Authors:  J Reichrath; J Kamradt; X H Zhu; X F Kong; W Tilgen; M F Holick
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

2.  Nobiletin-loaded composite penetration enhancer vesicles restore the normal miRNA expression and the chief defence antioxidant levels in skin cancer.

Authors:  Mahitab Bayoumi; Mona G Arafa; Maha Nasr; Omaima A Sammour
Journal:  Sci Rep       Date:  2021-10-12       Impact factor: 4.379

3.  Immunohistochemical evaluation of p53 and Ki67 expression in skin epithelial tumors.

Authors:  Effat Khodaeiani; Ashraf Fakhrjou; Mehdi Amirnia; Shahla Babaei-Nezhad; Farshid Taghvamanesh; Elham Razzagh-Karimi; Hossein Alikhah
Journal:  Indian J Dermatol       Date:  2013-05       Impact factor: 1.494

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.